Log in

ESSA Pharma SEC Filings & 10K Form (NASDAQ:EPIX)

$5.25
+0.14 (+2.74 %)
(As of 02/26/2020 05:30 AM ET)
Today's Range
$4.46
Now: $5.25
$5.28
50-Day Range
$5.11
MA: $5.56
$5.87
52-Week Range
$1.41
Now: $5.25
$6.14
Volume63,900 shs
Average Volume39,946 shs
Market Capitalization$108.99 million
P/E RatioN/A
Dividend YieldN/A
Beta2.01

SEC Filings

ESSA Pharma (NASDAQ:EPIX) SEC Filings

DateFilerForm TypeView
12/19/2019
7:11 PM
ESSA Pharma (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
11/12/2019
1:31 PM
ESSA Pharma (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G
11/05/2019
11:15 PM
ESSA Pharma (Filer)
Form EFFECT
11/05/2019
12:19 PM
ESSA Pharma (Filer)
Form F-3/A
10/30/2019
8:01 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/28/2019
12:02 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/21/2019
2:39 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/18/2019
3:51 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/08/2019
6:10 PM
ESSA Pharma (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
10/07/2019
2:18 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2019
8:38 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/19/2019
10:54 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/06/2019
4:22 PM
Clarus Lifesciences III, L.P. (Filed by)
ESSA Pharma (Subject)
Form SC 13D/A
09/05/2019
12:36 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/30/2019
2:31 PM
ESSA Pharma (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Form SC 13G
08/30/2019
1:01 PM
ESSA Pharma (Filer)
Form D
Notice of Exempt Offering of Securities 
08/29/2019
8:44 AM
ESSA Pharma (Subject)
Soleus Capital, LLC (Filed by)
Form SC 13G
08/27/2019
8:36 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/23/2019
10:56 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2019
7:48 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/31/2019
7:39 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2019
7:51 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/15/2019
8:50 AM
ESSA Pharma (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Form SC 13D/A
07/15/2019
8:10 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/08/2019
3:37 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/26/2019
8:34 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2019
8:18 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2019
7:42 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2019
10:44 AM
ESSA Pharma (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Form SC 13D
05/16/2019
9:05 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/10/2019
7:00 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/06/2019
7:12 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2019
9:02 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/17/2019
7:59 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/12/2019
6:47 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/28/2019
4:26 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/28/2019
4:17 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/18/2019
7:43 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/14/2019
7:24 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/13/2019
2:26 PM
ESSA Pharma (Subject)
Omega Fund IV, L.P. (Filed by)
Form SC 13D
02/13/2019
10:38 AM
ESSA Pharma (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Form SC 13G/A
02/07/2019
4:27 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/13/2018
4:21 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/13/2018
3:28 PM
ESSA Pharma (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
11/06/2018
12:13 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/22/2018
8:49 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/17/2018
4:17 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
ESSA Pharma (Subject)
Form SC 13G/A
08/29/2018
7:19 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2018
6:18 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/17/2018
11:15 PM
ESSA Pharma (Filer)
Form EFFECT
07/12/2018
2:41 PM
ESSA Pharma (Filer)
Form F-3/A
06/28/2018
4:22 PM
ESSA Pharma (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
06/19/2018
11:57 AM
Clarus Lifesciences III, L.P. (Filed by)
ESSA Pharma (Subject)
Form SC 13D/A
05/18/2018
4:29 PM
ESSA Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/18/2018
4:27 PM
ESSA Pharma (Filer)
Form S-8 POS
04/26/2018
8:10 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2018
6:45 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2018
6:59 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/20/2018
12:47 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/29/2018
7:12 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/09/2018
1:29 PM
ESSA Pharma (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Form SC 13G/A
02/23/2018
11:47 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2018
7:47 AM
ESSA Pharma (Subject)
Flynn James E (Filed by)
Form SC 13G/A
02/13/2018
1:14 PM
AWM Investment Company, Inc. (Filed by)
ESSA Pharma (Subject)
Form SC 13G/A
02/12/2018
4:25 PM
ESSA Pharma (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Form SC 13G/A
02/09/2018
1:25 PM
ESSA Pharma (Subject)
Omega Fund IV, L.P. (Filed by)
Form SC 13G/A
02/04/2018
11:15 PM
ESSA Pharma (Filer)
Form EFFECT
01/26/2018
8:09 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/26/2018
8:08 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2018
4:25 PM
ESSA Pharma (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
01/19/2018
4:25 PM
ESSA Pharma (Filer)
Form SUPPL
01/17/2018
6:10 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/16/2018
4:08 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
ESSA Pharma (Subject)
Form SC 13G
01/16/2018
8:23 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/09/2018
8:01 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/03/2018
6:44 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/22/2017
4:08 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/18/2017
6:48 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/13/2017
8:40 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2017
8:41 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2017
8:29 PM
ESSA Pharma (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
This page was last updated on 2/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel